Novartis brings Reinhardt back to the fold as Vasella steps down
This article was originally published in Scrip
Executive Summary
Novartis' long-time chairman and former CEO Daniel Vasella is to leave the board at its annual general meeting on 22 February, the company announced with its fourth quarter and full year 2012 results today.